Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Antibe Therapeutics Inc(Pre-Merger)
ATBPF
Healthcare
Biotechnology
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,...
otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (OTCID:ATBPF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(33)
•••
Inthepez
X
Comment by
Inthepez
on Mar 27, 2024 3:17pm
RE:24.9Mil cash 🥒
Silly dumpster aka Czechcashings. why are you so obsessed with ATE? Why are you wasting your time constantly posting about a company that has "better than 50% chance of going under
...more
(1512)
•••
Duster340
X
Post by
Duster340
on Mar 27, 2024 3:07pm
24.9Mil cash 🥒
as of dec/31/2023, the cash burn is aprox 1Mil per month by the end of this month cash will be 21.9 the clock is ticking. iam hearing nothing but silence. they are in a pickle will be
...more
Blue Sky Uranium Advances Ivana Project with Metallurgical Test Program
posted May 12, 2026 9:00am by
Blue Sky Uranium Corp.
-
|
The Company announced that its joint venture operating company Ivana Minerales S.A. has executed service agreements with M3 Engineering & Technology and the Saskatchewan Research Council to support engineering and metallurgical testing programs for the Ivana Uranium-Vanadium Project in Argentina ...read more
(33)
•••
Inthepez
X
Comment by
Inthepez
on Mar 26, 2024 9:12pm
RE:RE:RE:It does not make a lot of sense
Then why are you wasting your time constantly posting about a company that has "better than 50% chance of going under"? Peasant penny flipper lol!
(17)
•••
mstrmnds
X
Post by
mstrmnds
on Mar 26, 2024 3:01pm
Insurance
Do Canadian institutions like Export Development Canada provide insurance as collaterol in unfavourable international rulings against Canadian companies? This may be an avenue to explore...
(17)
•••
mstrmnds
X
Comment by
mstrmnds
on Mar 26, 2024 2:55pm
RE:It does not make a lot of sense
Because it's not up to Nuance to decide. The payment terms are not in Nuance's control and is subject to fair negotiation. Antibe controls the cash and can drag out repayment until
...more
(1512)
•••
Duster340
X
Comment by
Duster340
on Mar 26, 2024 11:39am
RE:RE:It does not make a lot of sense
reality is starting to set in with forestview "if ate goes bankrupt" he says, so my question is why would you invest in a company that has a better than 50% chance of going under. that
...more
(22)
•••
Forestview
X
Comment by
Forestview
on Mar 26, 2024 10:19am
RE:It does not make a lot of sense
Here comes Duster spewing unsubstantiated claims that are not rooted in anything other than his personal opinion. Again, if ATE goes bankrupt, Nuance is a creditor. They will not get
...more
(1512)
•••
Duster340
X
Post by
Duster340
on Mar 26, 2024 9:27am
It does not make a lot of sense
that nuance would burn through there own cash to let antibe carry on with the P2 trials. what if the drug is unsuccessful? the burden of bringing the drug to a point where there would be
...more
(55)
•••
Harper75
X
Comment by
Harper75
on Mar 26, 2024 9:24am
RE:Antibe is over the barrel (binding arbitration)
Your motivation is showing....
(1512)
•••
Duster340
X
Post by
Duster340
on Mar 26, 2024 9:11am
Antibe is over the barrel (binding arbitration)
the arbitrator has found in favor of Nuance Pharma in the dispute regarding the license agreement for the commercialization of otenaproxesul in the Greater China region. The confidential ruling from
...more
(17)
•••
mstrmnds
X
Comment by
mstrmnds
on Mar 26, 2024 3:26am
RE:True Value
It's an additional cost to take the drug(s) to market but in the greater scheme of things it's a relatively small price to pay. The money wasn't even Antibe's (chronic indication
...more
(17)
•••
mstrmnds
X
Post by
mstrmnds
on Mar 26, 2024 2:36am
True Value
If capital can significantly change the valuation of a company then what's the true valuation of a P2 company in acute pain with a disruptive lead drug?
(1512)
•••
Duster340
X
Post by
Duster340
on Mar 25, 2024 10:01am
Update 📉
looks like antibe wants to move lower. no news this morning, last week of the month!. it is white knuckle time for anyone invested. hopefully not an end of day friday news release, we know those are
...more
(4)
•••
FesticleShwartz
X
Comment by
FesticleShwartz
on Mar 23, 2024 8:53am
RE:Update
Thanks for the update! Much appreciated
(13)
•••
Ryeman40
X
Post by
Ryeman40
on Mar 22, 2024 7:56pm
Thanks
Forestview for updating the board with your conversations with Dan. We need more people who want to discuss facts about a company than would rather spew conjecture about said company. I've emailed
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
MindBio Develops Fatigue Prediction Model using Speech Analytics and AI
AI Beyond the Data Center: The Rise of Computing Everywhere
Podcasts